www.alk.net
  • Your allergy
    • What is allergy
      • House dust mite allergy
      • Pollen allergy
      • Living with allergy
      • Socio-economic impact
    • What is allergic asthma
    • How is allergy diagnosed
    • Treating allergy
  • Our solutions
    • Consumer healthcare
    • Diagnostics
    • Allergy vaccines
      • Production
    • Emergency medicine
  • Our science
    • Scientific focus
    • Science & technology
    • Pipeline
    • Digital innovation
    • Clinical data sharing
    • Collaboration & partnerships
    • Healthcare Professionals
      • Allergy Immunotherapy
      • Reweal
      • Clinical trials
      • Webinars
      • The Henning Lowenstein Research Award
  • Our company
    • Press
    • Our strategy
    • Our leadership
    • Our history
    • Corporate governance
  • Sustainability
  • Investors
    • Overview
    • Financial reporting
      • Risk management
      • Reporting standards
      • Auditors
    • Governance
      • Executive Leadership Team
      • Board of Directors
    • News & Events
      • Company Releases
      • Company releases (DK)
      • Webcasts & presentations
      • Investor calendar
      • Capital Markets Day 2024
    • The Share
      • Dividend history
      • Analyst coverage
      • Analyst estimates
      • Shareholder information
      • Authorizations
    • Contact IR
    • Annual general meeting
      • Annual general meeting (DK)
    • Capital Markets Day 2024
  • Careers
    • Working at ALK
    • Vacant positions
    • Cultural Beliefs
  • Select country
Search

News release

Links: 
Company Releases
Company releases (DK)
Webcasts & presentations
Investor calendar
Capital Markets Day 2024

« Back

ALK-Abelló has appointed Jørgen Damsbo Andersen new Executive Vice President of Business Operations & International Marketing and member of the Board of Management

May 30, 2007

PDF Version

Supporting Materials:
English version
ALK-Abelló management change
Summary: ALK-Abelló has appointed Jørgen Damsbo Andersen new Executive Vice President of Business Operations & International Marketing and member of the Board of Management of ALK-Abelló A/S.
The Board of Directors of ALK-Abelló today appointed Jørgen Damsbo Andersen new Executive Vice President of Business Operations & International Marketing and member of the Board of Management, succeeding Anders Hedegaard, who will be pursuing a career outside the company. It is expected that Jørgen Damsbo Andersen will take up his new position on November 1, 2007, at the latest.
 
Jørgen Damsbo Andersen (47) is currently in charge of ALK-Abelló’s Northern European Region. He joined ALK-Abelló in 2006 and has extensive experience from previous jobs in the pharmaceutical industry with companies such as Novo Nordisk, UCB/Celltech and Orion Pharma. Jørgen Damsbo Andersen holds an MSc in Economics and Business Administration from the Copenhagen Business School.
  • Email Alerts

    Email Alerts

  • Downloads

    Downloads

  • RSS

    RSS

  • Print

    Print

  • Share

    Share

  • English

    English

  • Search

    Search




Select Country Menu

  • Change Country

Quick Links

  • Contact us
  • News
  • Media
  • Vacant jobs
  • Products

ALK Footer Copyright Text

ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Legal disclaimer © ALK ∙ All rights reserved